Press Release

Press Release Banner Image

Altria Statement on FDA’s Proposed New Steps

Company Release - 11/15/2018 11:54 AM ET

RICHMOND, Va.--(BUSINESS WIRE)-- Today, Murray Garnick, Executive Vice President and General Counsel, Altria Group, Inc., issued the following statement in response to FDA’s announcements:

“We welcome FDA’s efforts to address the underage use of e-vapor products. That is why we believe Congress should raise the legal age of purchase for all tobacco products to 21. We also applaud FDA’s continued recognition of the potential for innovative, less harmful products that can deliver nicotine to adults who want them.

We continue to believe that a total ban on menthol cigarettes or flavored cigars would be an extreme measure not supported by the science and evidence. We expect that establishing product standards on menthol cigarettes and flavored cigars will be a multi-year, deliberative process, and we will be fully engaged throughout.

None of FDA’s proposed actions is self-executing. Each will require further action by FDA.”

As of the third quarter, PM USA’s menthol retail share was 10.2%, or approximately 20% of PM USA’s retail share.

Altria’s Profile

Altria’s wholly-owned subsidiaries include Philip Morris USA Inc. (PM USA), U.S. Smokeless Tobacco Company LLC, John Middleton Co., Sherman Group Holdings, LLC and its subsidiaries, Nu Mark LLC, Ste. Michelle Wine Estates Ltd. and Philip Morris Capital Corporation. Altria holds an equity investment in Anheuser-Busch InBev SA/NV.

The brand portfolios of Altria’s tobacco operating companies include Marlboro®, Black & Mild®, Copenhagen®, Skoal®, MarkTen® and Green Smoke®. Ste. Michelle produces and markets premium wines sold under various labels, including Chateau Ste. Michelle®, Columbia Crest®, 14 Hands® and Stag’s Leap Wine Cellars, and it imports and markets Antinori®, Champagne Nicolas Feuillatte, Torres® and Villa Maria Estateproducts in the United States. Trademarks and service marks related to Altria referenced in this release are the property of Altria or its subsidiaries or are used with permission. More information about Altria is available at altria.com and on the Altria Investor app.

Take a closer look at Altria and its companies on altria.com.
Follow Altria on Twitter at @AltriaNews.

Altria Client Services
Investor Relations
804-484-8222
or
Altria Client Services
Media Relations
(804) 484-8897

Source: Altria Group, Inc.